Can patients with Duchenne muscular dystrophy (DMD) experience chest pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chest Pain in Duchenne Muscular Dystrophy (DMD)

Yes, patients with Duchenne muscular dystrophy can experience chest pain, particularly as a manifestation of the cardiomyopathy that develops as part of the disease progression. 1

Cardiac Involvement in DMD

  • DMD is an X-linked genetic disorder affecting approximately 1 in 5000 live male births, characterized by progressive loss of muscle function due to mutations in the dystrophin gene 2
  • Historically, respiratory failure was the most common cause of death, but with improved respiratory support, cardiomyopathy has become an increasingly important source of morbidity and mortality 2
  • Cardiomyopathy in DMD typically presents as a hypokinetic, dilated phenotype that progressively worsens with age 3

Chest Pain Presentation in DMD

  • Chest pain with troponin elevation has been documented in DMD patients, indicating acute cardiac events that may represent significant progression of cardiomyopathy 1
  • These episodes can present as:
    • Primary complaint of acute chest pain 1
    • Secondary myocardial injury during systemic illness requiring hospitalization 1
  • During these events, patients may show:
    • Diffuse ST changes on electrocardiogram 1
    • Elevated troponin levels (which typically normalize with supportive care) 1
    • Deterioration of left ventricular ejection fraction (LVEF) 1
    • Increased late gadolinium enhancement on cardiac MRI, indicating progression of myocardial fibrosis 1

Cardiac Manifestations in DMD

  • Only about 30% of boys with DMD have cardiac symptoms at the time of cardiomyopathy diagnosis, making it often clinically silent 2
  • DMD cardiomyopathy is characterized by:
    • Less left ventricular enlargement at diagnosis compared to other forms of dilated cardiomyopathy 2
    • Higher mortality rate than other dilated cardiomyopathies 2
    • Typical ECG findings including increased R/S ratio in right precordial leads, deep Q waves in lateral leads, conduction abnormalities, and arrhythmias 4
    • Subepicardial fibrosis in the inferolateral wall as the typical cardiac MRI lesion 4

Clinical Implications and Management

  • Chest pain episodes with troponin elevation may represent an important pathophysiological mechanism in cardiomyopathy progression in DMD patients 1
  • This clinical presentation is under-recognized but significant as it may indicate acute left ventricular dysfunction and development or progression of myocardial fibrosis 1
  • Regular cardiac care is crucial in DMD management 3
  • Early recognition and prophylactic use of angiotensin converting enzyme inhibitors (ACEIs) are the mainstay therapeutic strategy to delay the incidence of DMD cardiomyopathy 3, 4
  • Addition of beta-blockers to ACEIs has shown improvement in left ventricular systolic function in muscular dystrophy patients 4

Monitoring Recommendations

  • Cardiac MRI is increasingly recommended for surveillance of myocardial damage and function in DMD patients, as it can detect early changes and fibrosis that may not be visible on echocardiography 2
  • Tissue Doppler echocardiography can be used to identify early changes of cardiomyopathy and detect progressive cardiac damage 4
  • Patients presenting with chest pain should receive comprehensive cardiac evaluation including ECG, troponin measurement, and cardiac imaging 1

In conclusion, chest pain in DMD patients should be taken seriously as it may indicate significant cardiac involvement and progression of cardiomyopathy, which is a leading cause of morbidity and mortality in this population.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.